Age Related Macular Degeneration Drug Market Report

Global and Region Age Related Macular Degeneration Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：198
  • REPORT CODE：GMM982903
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Age Related Macular Degeneration Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Age Related Macular Degeneration Drugmarket, defines the market attractiveness level of Age Related Macular Degeneration Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Age Related Macular Degeneration Drug industry, describes the types of Age Related Macular Degeneration Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Age Related Macular Degeneration Drug market and the development prospects and opportunities of Age Related Macular Degeneration Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Age Related Macular Degeneration Drug market in Chapter 13.

    By Player:

    • Bayer HealthCare

    • Novartis

    • Roche

    • Regeneron Pharmaceuticals

    • Kanghong Pharma

    By Type:

    • Lucentis

    • Eylea

    • Avastin

    • Other

    By End-User:

    • Hospitals

    • Clinics

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Age Related Macular Degeneration Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Age Related Macular Degeneration Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Age Related Macular Degeneration Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Age Related Macular Degeneration Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Age Related Macular Degeneration Drug Market Analysis and Outlook to 2022

    • 7.1 Global Age Related Macular Degeneration Drug Consumption (2017-2022)

    • 7.2 United States Age Related Macular Degeneration Drug Consumption (2017-2022)

    • 7.3 Europe Age Related Macular Degeneration Drug Consumption (2017-2022)

    • 7.4 China Age Related Macular Degeneration Drug Consumption (2017-2022)

    • 7.5 Japan Age Related Macular Degeneration Drug Consumption (2017-2022)

    • 7.6 India Age Related Macular Degeneration Drug Consumption (2017-2022)

    • 7.7 South Korea Age Related Macular Degeneration Drug Consumption (2017-2022)

    8 Region and Country-wise Age Related Macular Degeneration Drug Market Analysis and Outlook to 2028

    • 8.1 Global Age Related Macular Degeneration Drug Consumption Forecast (2022-2028)

    • 8.2 United States Age Related Macular Degeneration Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Age Related Macular Degeneration Drug Consumption Forecast (2022-2028)

    • 8.4 China Age Related Macular Degeneration Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Age Related Macular Degeneration Drug Consumption Forecast (2022-2028)

    • 8.6 India Age Related Macular Degeneration Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Age Related Macular Degeneration Drug Consumption Forecast (2022-2028)

    9 Global Age Related Macular Degeneration Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Age Related Macular Degeneration Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Lucentis Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Eylea Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Avastin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Age Related Macular Degeneration Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Age Related Macular Degeneration Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Age Related Macular Degeneration Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Lucentis Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Eylea Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Avastin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Age Related Macular Degeneration Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Age Related Macular Degeneration Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Age Related Macular Degeneration Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Age Related Macular Degeneration Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Age Related Macular Degeneration Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Age Related Macular Degeneration Drug Market Competitive Analysis

    • 14.1 Bayer HealthCare

      • 14.1.1 Bayer HealthCare Company Details

      • 14.1.2 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bayer HealthCare Age Related Macular Degeneration Drug Product and Service

    • 14.2 Novartis

      • 14.2.1 Novartis Company Details

      • 14.2.2 Novartis Age Related Macular Degeneration Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novartis Age Related Macular Degeneration Drug Product and Service

    • 14.3 Roche

      • 14.3.1 Roche Company Details

      • 14.3.2 Roche Age Related Macular Degeneration Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Roche Age Related Macular Degeneration Drug Product and Service

    • 14.4 Regeneron Pharmaceuticals

      • 14.4.1 Regeneron Pharmaceuticals Company Details

      • 14.4.2 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product and Service

    • 14.5 Kanghong Pharma

      • 14.5.1 Kanghong Pharma Company Details

      • 14.5.2 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Age Related Macular Degeneration Drug

    • Figure Age Related Macular Degeneration Drug Picture

    • Table Global Age Related Macular Degeneration Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Age Related Macular Degeneration Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Age Related Macular Degeneration Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Age Related Macular Degeneration Drug Consumption by Country (2017-2022)

    • Figure United States Age Related Macular Degeneration Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Age Related Macular Degeneration Drug Consumption and Growth Rate (2017-2022)

    • Figure China Age Related Macular Degeneration Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Age Related Macular Degeneration Drug Consumption and Growth Rate (2017-2022)

    • Figure India Age Related Macular Degeneration Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Age Related Macular Degeneration Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Age Related Macular Degeneration Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Age Related Macular Degeneration Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Age Related Macular Degeneration Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Age Related Macular Degeneration Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Age Related Macular Degeneration Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Age Related Macular Degeneration Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Age Related Macular Degeneration Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lucentis Consumption and Growth Rate (2017-2022)

    • Figure Global Eylea Consumption and Growth Rate (2017-2022)

    • Figure Global Avastin Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Lucentis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Eylea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Avastin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Age Related Macular Degeneration Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Age Related Macular Degeneration Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Bayer HealthCare (Foundation Year, Company Profile and etc.)

    • Table Bayer HealthCare Age Related Macular Degeneration Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer HealthCare Age Related Macular Degeneration Drug Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Age Related Macular Degeneration Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Age Related Macular Degeneration Drug Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Age Related Macular Degeneration Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Age Related Macular Degeneration Drug Product and Service

    • Table Regeneron Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product and Service

    • Table Kanghong Pharma (Foundation Year, Company Profile and etc.)

    • Table Kanghong Pharma Age Related Macular Degeneration Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kanghong Pharma Age Related Macular Degeneration Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US